NCT04411758View on ClinicalTrials.gov

Propolis for Patients With Chronic Kidney Disease.

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 12, 2021

Primary Completion Date

December 29, 2023

Study Completion Date

December 31, 2023

Conditions
Chronic Kidney DiseasesInflammation
Interventions
DIETARY_SUPPLEMENT

Propolis

Four capsules (400mg/day) containing dry EPP-AF® green propolis extract for 2 months and after washout, more two months crossover

DIETARY_SUPPLEMENT

Placebo

Four capsules (400mg/day) containing magnesium stearate, silicon dioxide and microcrystalline cellulose for 2 months and after washout, more two months crossover

Trial Locations (1)

Unknown

Denise Mafra, Niterói

All Listed Sponsors
lead

Universidade Federal Fluminense

OTHER

NCT04411758 - Propolis for Patients With Chronic Kidney Disease. | Biotech Hunter | Biotech Hunter